{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:29:05Z","timestamp":1759541345367},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.brainres.2009.04.028","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T08:17:31Z","timestamp":1240388251000},"page":"171-179","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats"],"prefix":"10.1016","volume":"1276","author":[{"given":"Lu","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maowen","family":"Ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2009.04.028_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(00)01461-0","article-title":"Stimulatory and inhibitory effects of adenosine A(2A) receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1\/2 in PC12 cells","volume":"292","author":"Arslan","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2009.04.028_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2009.04.028_bib3","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1523\/JNEUROSCI.16-15-04707.1996","article-title":"Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine","volume":"16","author":"Berhow","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/45251","article-title":"Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons","volume":"402","author":"Bibb","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2009.04.028_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/syn.10112","article-title":"Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats","volume":"46","author":"Bove","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2009.04.028_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2005.04190.x","article-title":"Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism","volume":"22","author":"Brown","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib7","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","article-title":"Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB","volume":"17","author":"Deak","year":"1998","journal-title":"Embo J."},{"key":"10.1016\/j.brainres.2009.04.028_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/o04-121","article-title":"The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling","volume":"83","author":"Dunn","year":"2005","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.brainres.2009.04.028_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2004.02.014","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders","volume":"10","author":"Ferre","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2009.04.028_bib11","first-page":"262","article-title":"Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine","volume":"55","author":"Fredholm","year":"1997","journal-title":"Med. Biol."},{"key":"10.1016\/j.brainres.2009.04.028_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1471-4159.2000.740807.x","article-title":"Decreased protein phosphatase 2A activity in hippocampal long-term potentiation","volume":"74","author":"Fukunaga","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2009.04.028_bib13","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1212\/WNL.52.8.1673","article-title":"Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys","volume":"52","author":"Grondin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2009.04.028_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2009.04.028_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2009.04.028_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000081227.84197.0B","article-title":"Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD","volume":"61","author":"Hauser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2009.04.028_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1353-8020(02)00115-3","article-title":"The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease","volume":"9","author":"Jenner","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2009.04.028_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/exnr.2000.7350","article-title":"Combined use of the adenosine A2A antagonist KW-6002 with or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys","volume":"162","author":"Kanda","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2009.04.028_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0955-0674(99)00075-7","article-title":"Protein phosphatases and the regulation of mitogen-activated protein kinase signalling","volume":"12","author":"Keyse","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.brainres.2009.04.028_bib20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.52.9.1916","article-title":"Theophylline increases \u201con\u201d time in advanced parkinsonian patients","volume":"52","author":"Kostic","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2009.04.028_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/mol.58.4.771","article-title":"Adenosine A(2A) receptors are colocalized with and activate G(olf) in rat striatum","volume":"58","author":"Kull","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2009.04.028_bib22","first-page":"309","article-title":"Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough","volume":"3","author":"Lang","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2009.04.028_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature00817","article-title":"Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine","volume":"418","author":"Lindskog","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2009.04.028_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0092-8674(95)90401-8","article-title":"Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation","volume":"80","author":"Marshall","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2009.04.028_bib25","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1073\/pnas.220410397","article-title":"Amplification of dopaminergic signaling by a positive feedback loop","volume":"97","author":"Nishi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.04.028_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(98)00724-0","article-title":"Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen","volume":"808","author":"Ouimet","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.04.028_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00726-001-0118-2","article-title":"Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease","volume":"23","author":"Oh","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.brainres.2009.04.028_bib41","series-title":"The Rat Brain in Stereotaxic Coordinates, 4th ed.","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.brainres.2009.04.028_bib28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2009.04.028_bib29","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.1523\/JNEUROSCI.1661-06.2006","article-title":"Blockade of adenosine A2A receptors prevents protein phosphorylation in the striatum induced by cortical stimulation","volume":"26","author":"Quiroz","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/brain\/121.3.527","article-title":"Corticalmotor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia","volume":"121","author":"Rascol","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2009.04.028_bib31","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1523\/JNEUROSCI.13-03-01080.1993","article-title":"Adenosine A2A receptors regulate the gene expression of striatopallidal and striatonigral neurons","volume":"13","author":"Schiffmann","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0306-4522(97)00180-2","article-title":"Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas","volume":"80","author":"Svenningsson","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2009.04.028_bib33","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.10.059","article-title":"Evaluation of neuronal phosphoproteins as effectors of caffeine and mediators of striatal adenosine A2A receptor signaling","volume":"1129","author":"Sahin","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2009.04.028_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/syn.20011","article-title":"Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA","volume":"2","author":"Tomiyama","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2009.04.028_bib36","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1523\/JNEUROSCI.20-23-08701.2000","article-title":"Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties","volume":"20","author":"Valjent","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib37","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/j.1460-9568.2004.03278.x","article-title":"Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain","volume":"19","author":"Valjent","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2009.04.028_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.0408305102","article-title":"Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum","volume":"102","author":"Valjent","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2009.04.028_bib39","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1096\/fj.01-0125com","article-title":"Early activation of the p42\/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism","volume":"16","author":"Wyatt","year":"2002","journal-title":"Faseb J."},{"key":"10.1016\/j.brainres.2009.04.028_bib40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309007707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899309007707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T16:27:34Z","timestamp":1558283254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899309007707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":41,"alternative-id":["S0006899309007707"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2009.04.028","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}